Gland Pharma shares rally 6% as brokerages lift ratings, target prices ; here's (...)
Gland Pharma shares surged after strong Q1 results and positive commentary from brokerages citing a turnaround at its European unit Cenexi. EBITDA margins expanded to 24.4%, and net profit rose 50% YoY. Despite weak U.S. sales, growth in Europe and new launches supported the outlook. Brokerages (...)
Site référencé: The Economic Times
The Economic Times
US futures rise, shrugging off Trump’s chip levies
7/08/2025
Tilt towards equities a healthy trend in savings : RBI
7/08/2025
NSDL shares list at 10% premium, close higher
7/08/2025
Reports of curbs on weekly options expiry speculative : Sebi Chief
7/08/2025
Tariff timeline : Major developments in Trump's trade war
6/08/2025
No worries over credit demand growth : Guv
6/08/2025
